Manning & Napier Advisors LLC increased its stake in Medtronic plc. (NYSE:MDT) by 1.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,289,068 shares of the medical technology company’s stock after acquiring an additional 90,922 shares during the period. Medtronic comprises approximately 3.5% of Manning & Napier Advisors LLC’s portfolio, making the stock its largest position. Manning & Napier Advisors LLC owned about 0.39% of Medtronic worth $411,329,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in MDT. Parkside Financial Bank & Trust lifted its stake in Medtronic by 22.4% in the second quarter. Parkside Financial Bank & Trust now owns 1,146 shares of the medical technology company’s stock worth $102,000 after purchasing an additional 210 shares during the last quarter. BDO Wealth Advisors LLC bought a new stake in Medtronic in the second quarter worth $103,000. Motco lifted its stake in Medtronic by 8.7% in the second quarter. Motco now owns 1,239 shares of the medical technology company’s stock worth $110,000 after purchasing an additional 99 shares during the last quarter. Farmers National Bank bought a new stake in Medtronic in the first quarter worth $121,000. Finally, Blue Chip Partners Inc. bought a new stake in Medtronic in the third quarter worth $118,000. Institutional investors own 81.74% of the company’s stock.
In other news, EVP Bryan C. Hanson sold 16,000 shares of the company’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $79.02, for a total transaction of $1,264,320.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last ninety days, insiders have sold 48,000 shares of company stock valued at $3,837,920. Insiders own 0.31% of the company’s stock.
Medtronic plc. (MDT) opened at $81.54 on Friday. The company has a market cap of $110,280.00, a PE ratio of 22.40, a PEG ratio of 2.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.05 and a current ratio of 2.40. Medtronic plc. has a one year low of $69.35 and a one year high of $89.72.
Medtronic (NYSE:MDT) last issued its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, beating the consensus estimate of $0.99 by $0.08. The firm had revenue of $7.05 billion during the quarter, compared to the consensus estimate of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. The company’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.12 earnings per share. sell-side analysts predict that Medtronic plc. will post 4.77 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 2.26%. The ex-dividend date of this dividend is Thursday, December 28th. Medtronic’s dividend payout ratio (DPR) is 50.55%.
TRADEMARK VIOLATION WARNING: “Manning & Napier Advisors LLC Has $411.33 Million Position in Medtronic plc. (MDT)” was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.com-unik.info/2017/12/24/manning-napier-advisors-llc-has-411-33-million-position-in-medtronic-plc-mdt.html.
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.